NFE2L2 and hepatocellular carcinoma: Nevertheless, in contrast with the previous study, it has been reported that Api, via down-regulating of PI3K/Akt pathway, diminishes the expression of Nrf2 at both protein and mRNA levels which leads to a reduced expression of Nrf2-target genes in BEL-7402 cells (human hepatocellular carcinoma cells).